Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
The first vaccine against coronavirus disease could one day be made of mRNA. How is…
Messenger RNA (mRNA) technology is based on the idea that human cells can be used as on-demand factories to develop therapeutic proteins by giving them instructions in the form of mRNA. Although mRNA therapeutics and vaccines could be found in drug development pipelines before Covid-19 emerged, the pandemic suddenly moved the mRNA technology into the limelight.
Now, the world has seen mass vaccinations using mRNA-based vaccines developed by Moderna and Pfizer/BioNTech. But the mRNA technology holds promise for other indications as well, including cancer and rare diseases. Read on to learn how this new technology is moving into the mainstream with an influx of investments and new discoveries.
European Biotech Industry Report 2021
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations.
Go to ReportThe first vaccine against coronavirus disease could one day be made of mRNA. How is…
The German biotech CureVac -- which is developing an mRNA vaccine against coronavirus -- has…
An EU research project has launched with the aim of bringing mRNA treatments to a…
Based close to Berlin, Germany, the biotech startup Pantherna Therapeutics is developing a messenger RNA…
In one of the biggest ever funding rounds in European biotech, the German company BioNTech…
An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development…
With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The…
BioNTech, based in Mainz, Germany, has entered into a partnership with Pfizer worth up to…
BioNTech will dedicate its huge fundraising to develop personalized cancer immunotherapies using CAR-T, TCR and…
Moderna Therapeutics has started dosing patients with an mRNA-based personalized cancer vaccine that resembles another…
An interview never seen before. We brought together the founders and CEOs of the two…
AstraZeneca will work with Moderna Therapeutics to bring together to the market an mRNA version of Novartis' failed…